Content - IELSG-37

IELSG-37 - Mediastinal radiotherapy after Rituximab containing chemotherapy regimens to patients with Large B-Cell Lymphoma

For further information about the trial IELSG-37 please visit the IBCSG-Website: www.ielsg.org

Study Chair:

Dr. Luca Ceriani, IOSI, +41 91 811 86 72

Locations for this trial:

Istituto Oncologico della Svizzera Italiana IOSI
Via Ospedale
0 6500 Bellinzona
Inselspital
Freiburgstrasse 8
3010 Bern
Kantonsspital Olten
Baslerstrasse 150
0 4600 Olten
Kantonsspital St. Gallen
Rorschacher Strasse 95
0 9007 St. Gallen